Phillip Andrew Dennis, Chief Medical Officer at NovaBridge Biosciences (NBP), sold 8,494 shares at $0.66 ($6K) on 2026-06-18, disclosed to the SEC on 2026-06-22.
Open-market sale of $6k NBP by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.